The LATAM Ledger: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The LATAM Ledger.

Press releases published on September 8, 2026

6 hours ago

BioAge Labs Announces First Participant Dosed in QUELL-DME, a Phase 2 Trial of BGE-102, a Novel Oral NLRP3 Inhibitor, in Diabetic Macular Edema

Indeterminate GlobeNewswire

6 hours ago

Windward Bio announces positive Phase 2 results of WIN378 in asthma demonstrating significant improvements in lung function and airway inflammation with twice-yearly dosing, and initiates Phase 3

Indeterminate GlobeNewswire

6 hours ago

Clearmind Medicine Receives Yale IRB Approval, Enabling Patient Recruitment for Parts B and C of CMND-100 Phase I/II Trial, Following Positive Safety Results

Indeterminate GlobeNewswire

6 hours ago

CervoMed to Participate in September Investor Conferences

Indeterminate GlobeNewswire

6 hours ago

Nasus Pharma to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

6 hours ago

Domestic Metals Commences Drill Program at Smart Creek Project, Montana

Indeterminate GlobeNewswire

6 hours ago

Pyxis Oncology Appoints Thomas Civik Chief Executive Officer and Chairman of the Board

Indeterminate GlobeNewswire

7 hours ago

Newcore Gold Announces Appointment of Mr. Sulemanu Koney to its Board of Directors

Indeterminate GlobeNewswire

7 hours ago

Zenas BioPharma to Host Obexelimab IgG4-RD Investor Event

Indeterminate GlobeNewswire

7 hours ago

Invivyd to Participate in Upcoming September Investor Conferences

Indeterminate GlobeNewswire

7 hours ago

Infex Therapeutics presents new Phase IIa data for RESP-X at ERS Congress 2026, providing further evidence on exploratory efficacy endpoints supporting progression to later stage development

Indeterminate GlobeNewswire

7 hours ago

G3 Goldfields Provides Update on Listing

Indeterminate GlobeNewswire

7 hours ago

BrainChild Bio Initiates Pivotal Phase 2 Trial for BCB-276 CAR T cell Therapy for DIPG, a Deadly Pediatric Brain Cancer

Indeterminate GlobeNewswire

7 hours ago

BrainChild Bio Closes $116 Million Series A Financing

Indeterminate GlobeNewswire

7 hours ago

Lahontan Strengthens Technical, Engineering, and Business Development Team

Indeterminate GlobeNewswire

7 hours ago

OKYO Pharma to Participate in a Fireside Chat at the Cantor Global Healthcare Conference

Indeterminate GlobeNewswire

7 hours ago

Pharvaris Announces Positive Topline Data from CHAPTER-3 Pivotal Study of Deucrictibant XR for Prophylaxis of HAE Attacks

Indeterminate GlobeNewswire

7 hours ago

Bullish releases August 2026 monthly metrics

Indeterminate GlobeNewswire

7 hours ago

DPM Metals Extends Mineralization at Dumitru Potok with High-Grade Intercepts

Indeterminate GlobeNewswire

7 hours ago

Nova Minerals’ Marches towards Antimony Production with Arrival of Processing & Refining Equipment in Alaska

Indeterminate GlobeNewswire